Rituraj Upadhyay | Healthcare Data Analysis | Best Researcher Award

Posted on by ScienceFather

Dr. Rituraj Upadhyay | Healthcare Data Analysis | Best Researcher Award

The Ohio State University, United States

Author Profiles

Orcid

Google Scholar

Research Gate

Early Academic Pursuits 🎓

Dr. Rituraj Upadhyay began his academic journey with a strong foundation in medical education at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. There, he completed his Bachelor of Medicine and Surgery (MBBS) in 2014, followed by an MD in Radiation Oncology (2017). His early medical training was marked by a deep interest in radiotherapy and oncology, leading him to pursue a Diplomate of National Board (DNB) certification in Radiation Oncology. His academic endeavors during this time reflected a commitment to advancing medical knowledge and improving patient care through radiation oncology.

Professional Endeavors 🌍

Dr. Upadhyay’s professional career has been driven by a passion for advancing radiation oncology, particularly through his work in clinical and academic settings. His residency at The Ohio State University Wexner Medical Center (2021–2025) is a notable highlight in his professional journey, demonstrating his commitment to mastering the latest technologies and treatments in radiation oncology. Dr. Upadhyay’s time at renowned institutions like MD Anderson Cancer Center and Rutgers Cancer Institute of New Jersey has further solidified his standing as an emerging leader in the field. His pursuit of innovation and excellence is evident from his involvement in advanced radiation oncology fellowships and international research collaborations.

Contributions and Research Focus 🔬

Dr. Upadhyay’s research is at the forefront of radiation oncology, with a focus on improving treatment outcomes and minimizing side effects. He has contributed significantly to clinical trials and funded research, such as the “PRIMe-STAR trial” on progressive/recurrent intracranial meningiomas and the “AVATAR” system aimed at reducing anesthesia needs in pediatric radiotherapy. His research on stereotactic radiosurgery for brain metastases and radiation therapy for conditions like penile cancer and renal stereotactic ablative therapy underscores his diverse interests in cancer treatment. His studies have potential global impact, as reflected in his leadership role in multinational research endeavors.

Impact and Influence 🌟

Dr. Upadhyay’s influence extends beyond his research. As an educator and mentor, he actively shapes the next generation of radiation oncologists. His roles in mentoring medical students, residents, and fellows at institutions like The Ohio State University and Massachusetts General Hospital highlight his dedication to guiding aspiring professionals. He also plays a key role in enhancing the field through his involvement in various professional organizations such as the American Society for Radiation Oncology (ASTRO) and the Radiosurgery Society (RSS). His work as a guideline reviewer and committee member for several radiation oncology societies reflects his broad influence on the development of standards and best practices in the field.

Academic Cites 📚

Dr. Upadhyay’s research and academic work are well-regarded, with his contributions earning recognition through numerous awards and honors. Notable accolades include the American College of Radiation Oncology (ACRO) Best Abstract Award and the American Radium Society (ARS) Early Career Oncologist Award, which are testaments to his influential research on topics like stereotactic radiosurgery and palliative radiation therapy. These accolades further cement his reputation in the academic community, demonstrating the high regard in which his peers hold his research.

Technical Skills 💻

Dr. Upadhyay has developed a comprehensive set of technical skills that position him at the cutting edge of radiation oncology. His expertise spans advanced radiation therapy techniques such as stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), proton therapy, and image-guided brachytherapy. In addition, he is well-versed in cutting-edge technologies, including the use of artificial intelligence and machine learning in radiation oncology for treatment planning and quality assurance. His technical acumen is further demonstrated by his involvement in developing new approaches to enhance clinical outcomes for complex cancer cases.

Teaching Experience 📖

Dr. Upadhyay has dedicated substantial time to teaching and mentorship, sharing his expertise with medical students, residents, and fellow researchers. He has served as a moderator for educational webinars and a mentor for various research initiatives. His roles as a panelist and speaker at international conferences, such as the ASTRO Annual Meeting and the Ohio State University Cardio-Oncology Symposium, reflect his commitment to advancing education within the field of oncology. Through these initiatives, he has played a key role in shaping the future of radiation oncology education.

Legacy and Future Contributions 🔮

Dr. Upadhyay’s legacy in radiation oncology is already being established through his groundbreaking research and mentorship. His involvement in international clinical trials, such as the AVATAR system and the PRIMe-STAR trial, is likely to make a long-lasting impact on the clinical management of cancer patients globally. Looking forward, Dr. Upadhyay plans to continue advancing his research, particularly in the areas of stereotactic radiosurgery and precision medicine. His work promises to significantly shape the future of radiation oncology, particularly in improving treatment efficacy, minimizing side effects, and enhancing patient care across diverse populations.

 

Top Noted Publications 📖

Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas

Authors: Divya Yadav, Rituraj Upadhyay, Vinodh A. Kumar, Melissa M. Chen, Jason M. Johnson, Holly Langshaw, Brandon J. Curl, Maguy Farhat, Wasif Talpur, Thomas H. Beckham et al.

Journal: Practical Radiation Oncology

Year: 2024

Risk-Stratified Radiotherapy in Pediatric Cancer

Authors: Rituraj Upadhyay, Arnold C. Paulino

Journal: Cancers

Year: 2024

Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients

Authors: Rituraj Upadhyay, Brett Klamer, Jennifer Matsui, Vikram B. Chakravarthy, Thomas Scharschmidt, Nicholas Yeager, Bhuvana A. Setty, Timothy P. Cripe, Ryan D. Roberts, Jennifer H. Aldrink et al.

Journal: Cancers

Year: 2024

Quantifying the Risk and Dosimetric Variables of Symptomatic Brainstem Injury after Proton Beam Radiation in Pediatric Brain Tumors

Authors: Rituraj Upadhyay, Kaiping Liao, David R Grosshans, Susan L McGovern, Mary Frances McAleer, Wafik Zaky, Murali M Chintagumpala, Anita Mahajan, Debra Nana Yeboa, Arnold C Paulino

Journal: Neuro-Oncology

Year: 2022

Patterns of Failure after Radiation Therapy in Primary Spinal High-Grade Gliomas: A Single Institutional Analysis

Authors: Rituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, Arnold C Paulino, Mary Frances McAleer, Amol Ghia, Jing Li, Debra Nana Yeboa, Monica Loghin, Rebecca Harrison et al.

Journal: Neuro-Oncology Advances

Year: 2022

Chitchamai Ovatlarnporn | Drug development | Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Chitchamai Ovatlarnporn | Drug development | Best Researcher Award

Assist Prof Dr. Chitchamai Ovatlarnporn at Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hatyai, Songkhla, Thailand

👨‍🎓Professional Profiles

🧑‍🏫 Early Academic Pursuits

Dr. Chitchamai Ovatlarnporn’s academic journey began with a solid foundation in pharmacy. She earned her Bachelor of Pharmacy (Second Honours) from Songkhla University in 1990. Building on this, she went on to pursue higher education internationally, receiving a Master’s Degree in Biotechnology from the University of Kent at Canterbury in 1993, and later obtaining a Ph.D. in Chemistry from the University of Ottawa in 2000. This educational progression laid the groundwork for her distinguished career in pharmaceutical sciences, particularly in the areas of drug delivery systems, medicinal chemistry, and biotechnology.

💼 Professional Endeavors

Dr. Ovatlarnporn’s professional career has been deeply intertwined with both academic and research excellence. She holds a prominent position as an Associate Professor at the Faculty of Pharmaceutical Sciences, Prince of Songkla University (PSU), Thailand. In addition to her teaching responsibilities, she is a pivotal figure in the Department of Pharmaceutical Chemistry at PSU, where she focuses on cutting-edge pharmaceutical research, particularly related to drug development and delivery systems. Over the years, she has successfully combined her roles as an educator, researcher, and consultant in various national and international research projects.

Her expertise extends to consulting for product development and research with projects like Move World Together and Tech2BiZ, reflecting her dynamic role in fostering innovation within the pharmaceutical and biotechnology industries.

🔬 Contributions and Research Focus

Dr. Ovatlarnporn’s research is diverse and far-reaching, focusing primarily on drug delivery systems, pharmaceutical chemistry, and biotechnology. One of her major research interests lies in the development of nanotechnology-based drug delivery systems, such as the preparation and evaluation of nanomicelles for enhanced solubility and bioavailability of poorly water-soluble drugs like curcumin and resveratrol.

She has also made significant contributions to pharmacological research, investigating the antioxidant, anti-inflammatory, and anticancer properties of various medicinal plants and their bioactive compounds. Her work also includes genetic engineering, the synthesis of novel compounds, and the utilization of biopolymers for targeted drug delivery systems, particularly in colon-specific drug delivery.

🌍 Impact and Influence

Dr. Ovatlarnporn’s work has had a significant impact on both the academic and pharmaceutical industries. Her research on tetrhydrocurcumins, curcumin derivatives, and chitosan-based drug delivery systems has opened new avenues for cancer therapy, chronic disease management, and sustainable biopharmaceutical innovations.

Her published works are frequently cited in high-impact journals such as Food Bioscience, Journal of Drug Delivery Science and Technology, and Molecules, making her an influential researcher in her field. Her studies on natural compounds such as Viola stocksii and Tiliacora triandra have advanced the scientific understanding of their pharmacological potentials, contributing to the growing body of knowledge in natural product-based drug development.

📚 Academic Cites & Recognition

Dr. Ovatlarnporn has authored and co-authored numerous peer-reviewed papers, making significant contributions to the fields of medicinal chemistry, pharmaceutical biotechnology, and drug delivery systems. Notable publications include:

  • “Evaluation of the Anti-Inflammatory, Antioxidant, and Cytotoxic Potential of Cardamine Amara L.” published in Frontiers in Chemistry (Impact Factor: 5.5).
  • “Insights into the remarkable attenuation of hen egg white lysozyme amyloid fibril formation mediated by biogenic gold nanoparticles” in the International Journal of Biological Macromolecules (Impact Factor: 8.2).
  • Research on Acanthus ebracteatus and its bioactive properties, published in Molecules.

Her work is widely recognized, with her publications frequently cited by fellow researchers and practitioners in the pharmaceutical sciences, demonstrating her high standing in the global research community.

🛠 Technical Skills

Dr. Ovatlarnporn is proficient in a wide range of technical skills essential to her research work. These include:

  • Nanotechnology and Drug Delivery Systems: Expertise in the preparation and evaluation of drug formulations, particularly nanomicelles and nanoemulsions.
  • Medicinal Chemistry: Deep knowledge of bioactive natural products, their chemical properties, and potential therapeutic applications.
  • Pharmacological Research: Extensive experience in designing and conducting in vitro and in vivo studies to assess the biological activity of plant-based compounds.
  • Analytical Techniques: Skilled in HPLC, GC-MS, NMR, and spectroscopic methods for the identification and quantification of bioactive compounds.
  • Molecular Docking & Computational Studies: Proficient in using in silico models for studying molecular interactions and optimizing drug efficacy.

👨‍🏫 Teaching Experience

As an academic leader at Prince of Songkla University, Dr. Ovatlarnporn has had a profound influence on shaping the next generation of pharmaceutical scientists. Her teaching areas cover various aspects of medicinal chemistry, drug delivery systems, biotechnology, and pharmaceutical technology. She is known for integrating cutting-edge research findings into her curriculum, ensuring that students are exposed to the latest advancements in the field. Her mentoring has inspired numerous graduate students, many of whom have gone on to achieve their own academic and professional successes.

🌱 Legacy and Future Contributions

Looking forward, Dr. Ovatlarnporn is committed to advancing research on nanotechnology and its applications in targeted drug delivery systems. She aims to further her work on sustainable biopharmaceutical innovations and natural product-based therapies, especially in cancer treatment and chronic disease management. Her research in collaboration with industry partners promises to continue to bridge the gap between academic research and commercial product development, ensuring that her contributions have lasting real-world impact.

In the future, Dr. Ovatlarnporn plans to focus on enhancing the bioavailability of natural bioactive compounds, developing more efficient drug delivery platforms, and promoting interdisciplinary collaborations within the fields of pharmacy, biotechnology, and medicine. Her continued dedication to research excellence and academic mentorship ensures her legacy will live on in both the scientific community and the generations of students she has mentored.